Folic acid and safflower oil supplementation interacts and protects embryos from maternal diabetes-induced damage
Open Access
- 16 December 2011
- journal article
- research article
- Published by Oxford University Press (OUP) in Molecular Human Reproduction
- Vol. 18 (5), 253-264
- https://doi.org/10.1093/molehr/gar080
Abstract
Maternal diabetes increases the risk of embryo malformations. Folic acid and safflower oil supplementations have been shown to reduce embryo malformations in experimental models of diabetes. In this study we here tested whether folic acid and safflower oil supplementations interact to prevent embryo malformations in diabetic rats, and analyzed whether they act through the regulation of matrix metalloproteinases (MMPs), their endogenous inhibitors (TIMPs), and nitric oxide (NO) and reactive oxygen species production. Diabetes was induced by streptozotocin administration prior to mating. From Day 0.5 of pregnancy, rats did or did not receive folic acid (15 mg/kg) and/or a 6% safflower oil-supplemented diet. Embryos and decidua were explanted on Day 10.5 of gestation for further analysis of embryo resorptions and malformations, MMP-2 and MMP-9 activities, TIMP-1 and TIMP-2 levels, NO production and lipid peroxidation. Maternal diabetes induced resorptions and malformations that were prevented by folic acid and safflower oil supplementation. MMP-2 and MMP-9 activities were increased in embryos and decidua from diabetic rats and decreased with safflower oil and folic acid supplementations. In diabetic animals, the embryonic and decidual TIMPs were increased mainly with safflower oil supplementation in decidua and with folic acid in embryos. NO overproduction was decreased in decidua from diabetic rats treated with folic acid alone and in combination with safflower oil. These treatments also prevented increases in embryonic and decidual lipid peroxidation. In conclusion, folic acid and safflower oil supplementations interact and protect the embryos from diabetes-induced damage through several pathways related to a decrease in pro-inflammatory mediators.Keywords
This publication has 49 references indexed in Scilit:
- Therapeutic management of type 1 diabetes before and during pregnancyExpert Opinion on Pharmacotherapy, 2011
- Folic acid mitigated cardiac dysfunction by normalizing the levels of tissue inhibitor of metalloproteinase and homocysteine-metabolizing enzymes postmyocardial infarction in miceAmerican Journal of Physiology-Heart and Circulatory Physiology, 2010
- Understanding diabetic teratogenesis: Where are we now and where are we going?Birth Defects Research Part A: Clinical and Molecular Teratology, 2010
- Carbaprostacyclin, a PPARδ agonist, ameliorates excess lipid accumulation in diabetic rat placentasLife Sciences, 2010
- High-dose folate and dietary purines promote scavenging of peroxynitrite-derived radicals – Clinical potential in inflammatory disordersMedical Hypotheses, 2009
- Aspirin Inhibits MMP-2 and MMP-9 Expressions and Activities through Upregulation of PPARα/γ and TIMP Gene Expressions in ox-LDL-Stimulated Macrophages Derived from Human MonocytesPharmacology, 2008
- Tissue Inhibitors of Metalloproteinases in Cell Signaling: Metalloproteinase-Independent Biological ActivitiesScience Signaling, 2008
- Control of matrix metalloproteinase catalytic activityMatrix Biology, 2007
- Regulation of matrix biology by matrix metalloproteinasesCurrent Opinion in Cell Biology, 2004
- Dietary polyunsaturated fatty acid prevents malformations in offspring of diabetic ratsAmerican Journal of Obstetrics and Gynecology, 1996